List view / Grid view
Sino Biological announced the formal signing of a lease with Hines and initiation of construction on its new Centre for Bioprocessing (C4B) at its Levit Green facility in Houston, US.
Sino Biological’s “FucoFree” eukaryotic expression system provides high-yield and high-throughput afucosylated monoclonal antibody (mAb) production.
In this article, Sino Biological highlight the importance of recombinant protein expression using a baculovirus-insect cell system (BEVS) and application of BEVS.
Sino Biological, Inc. has announced a new contract research services partnership with Ainnocence, Inc.
Sino Biological, Inc. has announced the formation of two new operationally focused subsidiaries in China.
In this article, Sino Biological will highlight the applications of anti-IDs, and conclude with our two featured case studies on anti-ID development.
In this article, Sino Biological will highlight the design and engineering of bispecific antibodies, and bsAbs expression and production.
Sino Biological has announced that its new location in Houston, Texas, is now open, expanding the company geographically.
To support disease research, Sino Biological has deposited reagents for the Omicron variant to BEI Resources.
Sino Biological has developed recombinant Omicron Spike RBD protein and antibody reacting with Omicron to support the study of Omicron variant.
Sino Biological, Inc. has just launched a panel of research reagents for the newly identified Omicron variant (B.1.1.529) of the SARS-CoV-2 virus, which quickly raised concerns around the world due to the high number of mutations it carries, particularly the 30-plus mutations on the Spike protein.
Sino Biological is an international reagent supplier and service provider. The company specialises in recombinant protein production and antibody development.
A panel of SARS-CoV-2 reagents (e.g. antigens, antibodies, and kits) and influenza antigens have been developed to support the development of vaccines.
Sino Biological has developed 1,000+ cytokines and receptors, including growth factors, cytokines, chemokines, interferons, interleukins, etc.
5,000+ drug target reagents for antibody, small molecule drug discovery and development, including immune checkpoints, cytokines and kinases.
